FMO1 and steatosis: On the other hand, two genes (CYP1A2 and FMO1) were downregulated in hepatotoxicity pathway, two genes (SREBF1 and FASN) in steatosis, one each in necrosis (IPO4) and phospholipidosis (SLC2A3) pathways.